135 related articles for article (PubMed ID: 38132253)
41. The detection and significance of EGFR and BRAF in cell-free DNA of peripheral blood in NSCLC.
Yang Y; Shen X; Li R; Shen J; Zhang H; Yu L; Liu B; Wang L
Oncotarget; 2017 Jul; 8(30):49773-49782. PubMed ID: 28572536
[TBL] [Abstract][Full Text] [Related]
42. A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR.
Norton SE; Lechner JM; Williams T; Fernando MR
Clin Biochem; 2013 Oct; 46(15):1561-5. PubMed ID: 23769817
[TBL] [Abstract][Full Text] [Related]
43. Lessons learned from routine, targeted assessment of liquid biopsies for
Mondaca S; Offin M; Borsu L; Myers M; Josyula S; Makhnin A; Shen R; Riely GJ; Rudin CM; Ladanyi M; Yu HA; Li BT; Arcila ME
Acta Oncol; 2019 Nov; 58(11):1634-1639. PubMed ID: 31347936
[No Abstract] [Full Text] [Related]
44. Denaturation-Enhanced Droplet Digital PCR for Liquid Biopsies.
Fitarelli-Kiehl M; Yu F; Ashtaputre R; Leong KW; Ladas I; Supplee J; Paweletz C; Mitra D; Schoenfeld JD; Parangi S; Makrigiorgos GM
Clin Chem; 2018 Dec; 64(12):1762-1771. PubMed ID: 30274976
[TBL] [Abstract][Full Text] [Related]
45. Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value.
Alegre E; Fusco JP; Restituto P; Salas-Benito D; Rodríguez-Ruiz ME; Andueza MP; Pajares MJ; Patiño-García A; Pio R; Lozano MD; Gúrpide A; Lopez-Picazo JM; Gil-Bazo I; Perez-Gracia JL; Gonzalez A
Tumour Biol; 2016 Oct; 37(10):13687-13694. PubMed ID: 27473086
[TBL] [Abstract][Full Text] [Related]
46. Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatch.
Zou J; Duffy B; Slade M; Young AL; Steward N; Hachem R; Mohanakumar T
Hum Immunol; 2017 Apr; 78(4):342-349. PubMed ID: 28267558
[TBL] [Abstract][Full Text] [Related]
47. A Synthetic DNA Construct to Evaluate the Recovery Efficiency of Cell-Free DNA Extraction and Bisulfite Modification.
Goh SK; Cox DRA; Wong BKL; Musafer A; Witkowski T; Do H; Muralidharan V; Dobrovic A
Clin Chem; 2021 Sep; 67(9):1201-1209. PubMed ID: 34151944
[TBL] [Abstract][Full Text] [Related]
48. Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the
Russo IJ; Ju Y; Gordon NS; Zeegers MP; Cheng KK; James ND; Bryan RT; Ward DG
Bladder Cancer; 2018 Jan; 4(1):41-48. PubMed ID: 29430506
[TBL] [Abstract][Full Text] [Related]
49. A novel method for liquid-phase extraction of cell-free DNA for detection of circulating tumor DNA.
Janku F; Huang HJ; Pereira DY; Kobayashi M; Chiu CH; Call SG; Woodbury KT; Chao F; Marshak DR; Chiu RYT
Sci Rep; 2021 Oct; 11(1):19653. PubMed ID: 34608196
[TBL] [Abstract][Full Text] [Related]
50. Digital PCR-Based Detection of EGFR Mutations in Paired Plasma and CSF Samples of Lung Adenocarcinoma Patients with Central Nervous System Metastases.
Huang R; Xu X; Li D; Chen K; Zhan Q; Ge M; Zhou X; Liang X; Guan M
Target Oncol; 2019 Jun; 14(3):343-350. PubMed ID: 31161597
[TBL] [Abstract][Full Text] [Related]
51. A nanowire-based liquid biopsy method using cerebrospinal fluid cell-free DNA for targeted management of leptomeningeal carcinomatosis.
Choi W; Cho Y; Park SY; Hwang KH; Han JY; Lee Y
J Cancer Res Clin Oncol; 2021 Jan; 147(1):213-222. PubMed ID: 32705364
[TBL] [Abstract][Full Text] [Related]
52. Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction.
Janku F; Huang HJ; Fujii T; Shelton DN; Madwani K; Fu S; Tsimberidou AM; Piha-Paul SA; Wheler JJ; Zinner RG; Naing A; Hong DS; Karp DD; Cabrilo G; Kopetz ES; Subbiah V; Luthra R; Kee BK; Eng C; Morris VK; Karlin-Neumann GA; Meric-Bernstam F
Ann Oncol; 2017 Mar; 28(3):642-650. PubMed ID: 27993791
[TBL] [Abstract][Full Text] [Related]
53. A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance.
Wang W; Song Z; Zhang Y
Cancer Med; 2017 Jan; 6(1):154-162. PubMed ID: 28000387
[TBL] [Abstract][Full Text] [Related]
54. Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer Patients.
Leest PV; Boonstra PA; Elst AT; Kempen LCV; Tibbesma M; Koopmans J; Miedema A; Tamminga M; Groen HJM; Reyners AKL; Schuuring E
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32414097
[TBL] [Abstract][Full Text] [Related]
55. Using circulating cell-free DNA to monitor personalized cancer therapy.
Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
[TBL] [Abstract][Full Text] [Related]
56. Dynamic cfDNA Analysis by NGS in
Ma L; Li H; Wang D; Hu Y; Yu M; Zhang Q; Qin N; Zhang X; Li X; Zhang H; Wu Y; Lv J; Yang X; Yu R; Zhang S; Wang J
Front Oncol; 2021; 11():643199. PubMed ID: 33842353
[TBL] [Abstract][Full Text] [Related]
57. Detection of the JAK2 V617F Mutation in Urinary Cell-free DNA in Patients with Myeloproliferative Neoplasms.
Hosoi H; Hori Y; Fukutsuka K; Osuga M; Koh Y; Mushino T; Hanaoka N; Yamamoto N; Ohno H; Sonoki T
Intern Med; 2023 Nov; ():. PubMed ID: 38008450
[TBL] [Abstract][Full Text] [Related]
58. Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biases.
Soscia R; Della Starza I; De Novi LA; Ilari C; Ansuinelli M; Cavalli M; Bellomarino V; Cafforio L; Di Trani M; Cazzaniga G; Fazio G; Santoro A; Salemi D; Spinelli O; Tosi M; Terragna C; Robustelli V; Bellissimo T; Colafigli G; Breccia M; Chiaretti S; Di Rocco A; Martelli M; Guarini A; Del Giudice I; Foà R
Hematol Oncol; 2023 Feb; 41(1):50-60. PubMed ID: 36251440
[TBL] [Abstract][Full Text] [Related]
59. EGFR T790M mutation testing of non-small cell lung cancer tissue and blood samples artificially spiked with circulating cell-free tumor DNA: results of a round robin trial.
Fassunke J; Ihle MA; Lenze D; Lehmann A; Hummel M; Vollbrecht C; Penzel R; Volckmar AL; Stenzinger A; Endris V; Jung A; Lehmann U; Zeugner S; Baretton G; Kreipe H; Schirmacher P; Kirchner T; Dietel M; Büttner R; Merkelbach-Bruse S
Virchows Arch; 2017 Oct; 471(4):509-520. PubMed ID: 28884371
[TBL] [Abstract][Full Text] [Related]
60. EGFR T790M detection and osimertinib treatment response evaluation by liquid biopsy in lung adenocarcinoma patients with acquired resistance to first generation EGFR tyrosine kinase inhibitors.
Li C; Jia R; Liu H; Zhang B; Wang C
Diagn Pathol; 2018 Aug; 13(1):49. PubMed ID: 30103780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]